High-dose prescription amphetamine users face over five-fold increased risk of psychosis or mania, with 30 mg+ dextroamphetamine (40 mg Adderall) posing the highest risk, according to McLean Hospital research. The study, published in the American Journal of Psychiatry, highlights the need for dose consideration in prescribing stimulants, with 81% of psychosis or mania cases in high-dose users potentially preventable. No significant risk increase was observed with methylphenidate (Ritalin) use.